Navigation Links
Endologix Reports 22% Second Quarter 2011 Revenue Growth
Date:7/21/2011

IRVINE, Calif., July 21, 2011 /PRNewswire/ -- Endologix, Inc. (NASDAQ: ELGX), developer and marketer of innovative treatments for aortic disorders, today announced financial results for the three and six months ended June 30, 2011.

John McDermott, Endologix President and Chief Executive Officer, said, "We are pleased with our progress during the quarter and remain on track to achieve our growth and new product development goals for 2011.  In the second quarter, global revenue grew by 22% compared to the prior year and by 30% in the U.S. market, driven by the ongoing adoption of our endovascular AAA devices and the effectiveness of our sales force.  During the quarter we received FDA approval of our new AFX™Endovascular AAA System, which will provide clinicians with improved access, precise deployment and enhanced sealing characteristics.  We introduced AFX at the Society for Vascular Surgery annual meeting last month and received positive physician feedback."

Mr. McDermott added, "Our recently announced decision to accelerate the transition of our existing products to a direct sales force in Europe is an important step in becoming a leading player in the global endovascular AAA market.  We are already building relationships with physicians in Europe and look forward to working with them directly, starting on September 1, 2011.  Our development and regulatory programs for AFX, Ventana™ and Nellix® remain on track and we believe these new technologies will improve outcomes and significantly increase the number of AAA patients who can be treated with endovascular devices."

Financial ResultsTotal revenue in the second quarter of 2011 was $19.2 million, a 22% increase from $15.7 million in the same quarter of 2010, and a 3% increase from the first quarter of 2011.  Domestic revenue was $16.6 million, a 30% increase co
'/>"/>

SOURCE Endologix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Endologix Comments on Alleged Patent Infringement
2. Endologix Responds to Alleged Patent Infringement
3. Endologix to Report Third Quarter 2009 Financial Results on October 27, 2009
4. Endologix Reports 47% Third Quarter 2009 Revenue Growth
5. Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement
6. Endologix Enters Development Agreement and Exclusive License for Balloon Expandable Stent Technology
7. Endologix Receives CE Mark Approval for Expanded Line of Powerlink Products and PowerFit Aortic Extensions
8. Endologix to Report Third Quarter 2010 Financial Results on October 27, 2010
9. Endologix Announces Publication of Clinical Trial Results Supporting Anatomical Fixation with a Suprarenal Aortic Extension
10. Endologix to Present at Oppenheimer 21st Annual Healthcare Conference
11. Endologix Reports 30% Third Quarter 2010 Revenue Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014 ... of the "Global Advanced Wound Care and ... - Size, Share, Global Trends, Company Profiles, Demand, ... 2013 - 2020" report to their offering. ... advanced wound care and closure market (types, applications, ...
(Date:8/20/2014)... ARBOR, Mich. and PHOENIX ... non-profit corporation established to bring cutting-edge next-generation sequencing ... to cancer patients, today announced a collaboration with ... capabilities to characterize patient tissue samples from clinical ... sensitive or resistant to TESARO,s TSR-011.  This may lead ...
(Date:8/20/2014)... LAKE WORTH, Fla. , Aug. 20, 2014  Glades ... Florida , is proud to announce its expansion into ... , which will feature an 8,000-square-foot office space and ... is currently accepting applications for 100 open positions for the ... located at 4560 Lantana Road will serve as the chain,s ...
Breaking Medicine Technology:Global Advanced Wound Care and Closure Market (Types, Applications, End User and Geography) - Forecast to 2020 2Paradigm Announces Molecular Profiling Collaboration with TESARO, Inc. 2Glades Drugs Moves to New Corporate Headquarters, 100 Open Positions 2
... in Peer-Review Journal,Respiratory Medicine, SAN JOSE, Calif., ... Pulmonary Fibrosis (CPF) today announced a summary ... of the,largest databases of information on patients ... United States, was,published in Respiratory Medicine. The ...
... OBISPO, Calif.--(BUSINESS WIRE)--Mar 22, 2007 - FzioMed,Inc. announced ... on,novel, synthetic dermal fillers is being presented at ... March,22-24, 2007., In 2006, FzioMed launched Laresse Dermal ... the,company's patented polymer science. Laresse represents a completely,new ...
Cached Medicine Technology:Medical Journal Publishes First Large-Scale Survey Revealing,Experiences of IPF Patients 2Medical Journal Publishes First Large-Scale Survey Revealing,Experiences of IPF Patients 3Laresse Dermal Filler Research Presented at Anti-Aging World,Congress 2
(Date:8/20/2014)... 20, 2014 Botanica Day ... facial. Utilizing the new and popular stem cell ... fine lines and wrinkles and naturally repairs the ... highlighting the new service by offering clients a ... stem cell facial. , Pevonia® continues to be ...
(Date:8/20/2014)... -- Leaving the car at home and getting to work ... health, a new study indicates. Researchers looked at thousands ... percent of men and 72 percent of women drove to ... used public transit, and 14 percent of men and 17 ... to work weighed more and had higher levels of body ...
(Date:8/20/2014)... Chemically extracted acellular allogeneic nerve, from which ... have been removed, reduced postoperative immune rejection. ... neural substrates and base materials, such as ... can provide a good scaffold in the ... allogeneic nerve, similar to autologous nerve transplantation, ...
(Date:8/20/2014)... 20, 2014 Fresh from the cradle of ... sprung from the starting blocks. , Urbini, a new collection ... the Urbini Avi jogger to its lineup. , ... with a look inspired by the latest racing styles and ... , This versatile jogger offers a swift, smooth ride on ...
(Date:8/20/2014)... August 20, 2014 The National ... five-year, $1.24 million Science Education Partnership Award (SEPA) ... support NAHN’s collaborative project with the Hispanic Communications ... Careers. , This collaborative NIH R25 program has ... and linguistic diversity among health professionals by recruiting ...
Breaking Medicine News(10 mins):Health News:New Stem Cell Facial Unveiled at Botanica Day Spa 2Health News:New Stem Cell Facial Unveiled at Botanica Day Spa 3Health News:Want to Stay Slim? Leave the Car at Home 2Health News:Urbini Breezes Through Summer with New Jogging Stroller 2Health News:National Association of Hispanic Nurses (NAHN) Receives Five-Year Federal Grant from the National Institutes of Health (NIH) 2Health News:National Association of Hispanic Nurses (NAHN) Receives Five-Year Federal Grant from the National Institutes of Health (NIH) 3
... Irvine scientists will receive grants totaling $9.35 million to ... disease and traumatic brain injury. The grants from ... Oct. 21, to Dr. Henry Klassen, Leslie M. Thompson, ... the Sue and Bill Gross Stem Cell Research Center ...
... interdisciplinary approach to drug abuse and addiction research, The ... has been renewed as a "Center of Excellence" by ... National Institutes of Health. The designation comes with ... to further studies led by researchers and clinicians in ...
... University of California, San Diego School of Medicine indicates that ... plans that include parents and child, while at the same ... , The results were published today in the advanced online ... Boutelle, PhD, associate professor of pediatrics and psychiatry at UC ...
... (HealthDay News) -- A new study suggests that in women ... tissue in addition to a cancerous breast tumor is enough ... about how much of a "free margin" around a tumor ... the November issue of IJCP, the International Journal of ...
... A new research study conducted by Boston University ... significantly improve biennial mammography screening rates among inner city ... Journal of General Internal Medicine , indicate the importance ... patient populations. Breast cancer is the second ...
... , THURSDAY, Oct. 21 (HealthDay News) -- Over the ... in the United States will be 10 times greater ... that could affect cancer patients, access to treatment, according ... the number of patients requiring radiation therapy will increase ...
Cached Medicine News:Health News:UCI stem cell researchers to receive $9.35 million in state funding 2Health News:UCI stem cell researchers to receive $9.35 million in state funding 3Health News:UTHealth receives $11 million NIDA grant 2Health News:Parent-only treatment may be equally effective for children who are obese 2Health News:New Finding Suggests Safe Surgical Margins When Removing Breast Cancers 2Health News:BUSM study shows patient navigations improve mammography rates in minority women 2Health News:Demand for Radiation Therapy Predicted to Exceed Supply 2
The GII titanium anchor with nitinol arcs is used for soft tissue reattachment to bone. The GII's small size, high pull-out strength and wide range of clinical applications make it the anchor used by...
... loupe provides greater definition than a ... of view. The Hi-Res five element ... in a lightweight system., ,Order frame ... are supplied in a soft carrying ...
The Nevyas Drape Support is the simple and inexpensive way to establish a zone of comfort for your patients during ophthalmic surgery which requires draping over the nose and mouth. Packaged in sets ...
... The Chan Wristrest has become an important ... adjustable horseshoe bar encircles the patient's head and ... horseshoe bar facilitates easy draping especially when fluids ... out of the way for easy patient transfer ...
Medicine Products: